This column was originally published on Street Insight on Jan. 5 at 8 a.m. EST. It's being republished as a bonus for TheStreet.com and RealMoney.com readers. For more information about subscribing to Street Insight, please
Doug Kass shares his thoughts on his Allergan profit and discussing adding Dillard's to his list.
In-depth analysis by Doug Kass.